These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35372033)

  • 1. A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation.
    Lin Y; Zhang J; Arroyo A; Singal AG; Parikh ND; Lubman DM
    Front Oncol; 2022; 12():818001. PubMed ID: 35372033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Panel of Glycopeptides as Candidate Biomarkers for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation.
    Lin Y; Zhu J; Pan L; Zhang J; Tan Z; Olivares J; Singal AG; Parikh ND; Lubman DM
    J Proteome Res; 2021 Jun; 20(6):3278-3289. PubMed ID: 33929864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large Scale Screening and Quantitative Analysis of Site-Specific N-Glycopeptides from Human Serum in Early Alzheimer's Disease Using LC-HCD-PRM-MS.
    Pan L; Lin Y; Zhu J; Zhang J; Tan Z; Lubman DM
    J Proteomics Bioinform; 2022; 15(5):. PubMed ID: 37362028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS.
    Tan Y; Zhu J; Gutierrez Reyes CD; Lin Y; Tan Z; Wu Z; Zhang J; Cano A; Verschleisser S; Mechref Y; Singal AG; Parikh ND; Lubman DM
    ACS Omega; 2023 Apr; 8(13):12467-12480. PubMed ID: 37033807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis.
    Zhu J; Huang J; Zhang J; Chen Z; Lin Y; Grigorean G; Li L; Liu S; Singal AG; Parikh ND; Lubman DM
    J Proteome Res; 2020 Aug; 19(8):3452-3466. PubMed ID: 32412768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method.
    Lin Y; Zhu J; Zhang J; Dai J; Liu S; Arroyo A; Rose M; Singal AG; Parikh ND; Lubman DM
    ACS Omega; 2022 Jul; 7(26):22850-22860. PubMed ID: 35811936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM.
    Ma J; Sanda M; Wei R; Zhang L; Goldman R
    J Proteomics; 2018 Oct; 189():67-74. PubMed ID: 29427759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Analysis of α-1-Antitrypsin Glycosylation Isoforms in HCC Patients Using LC-HCD-PRM-MS.
    Yin H; Zhu J; Wang M; Yao ZP; Lubman DM
    Anal Chem; 2020 Jun; 92(12):8201-8208. PubMed ID: 32426967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
    Zhu J; Warner E; Parikh ND; Lubman DM
    Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS.
    Zhu J; Chen Z; Zhang J; An M; Wu J; Yu Q; Skilton SJ; Bern M; Ilker Sen K; Li L; Lubman DM
    J Proteome Res; 2019 Jan; 18(1):359-371. PubMed ID: 30370771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
    Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
    Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy integrating stepped fragmentation and glycan diagnostic ion-based spectrum refinement for the identification of core fucosylated glycoproteome using mass spectrometry.
    Cao Q; Zhao X; Zhao Q; Lv X; Ma C; Li X; Zhao Y; Peng B; Ying W; Qian X
    Anal Chem; 2014 Jul; 86(14):6804-11. PubMed ID: 24914453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRM-MS Quantitative Analysis of Isomeric
    Gutierrez Reyes CD; Huang Y; Atashi M; Zhang J; Zhu J; Liu S; Parikh ND; Singal AG; Dai J; Lubman DM; Mechref Y
    Metabolites; 2021 Aug; 11(8):. PubMed ID: 34436504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
    Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
    Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry.
    Ji ES; Hwang H; Park GW; Lee JY; Lee HK; Choi NY; Jeong HK; Kim KH; Kim JY; Lee S; Ahn YH; Yoo JS
    Anal Bioanal Chem; 2016 Nov; 408(27):7761-7774. PubMed ID: 27565792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of Core-Fucosylated Glycopeptides Based on the Y1+Fuc/Y1 Ratio in Low-Energy HCD Spectra.
    Chen Z; Shen J; Dong W; Li P; Xin M; Liu D; Jia L; Zhu B; Li W; Sun S
    Anal Chem; 2022 Dec; 94(50):17349-17353. PubMed ID: 36484784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.
    Darebna P; Novak P; Kucera R; Topolcan O; Sanda M; Goldman R; Pompach P
    J Proteomics; 2017 Feb; 153():44-52. PubMed ID: 27646713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized Fragmentation for Quantitative Analysis of Fucosylated N-Glycoproteins by LC-MS-MRM.
    Yuan W; Wei R; Goldman R; Sanda M
    Anal Chem; 2019 Jul; 91(14):9206-9212. PubMed ID: 31268672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Ramachandran P; Xu G; Huang HH; Rice R; Zhou B; Lindpaintner K; Serie D
    J Proteome Res; 2022 Apr; 21(4):1083-1094. PubMed ID: 35286803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of site and structure specific core fucosylation in liver cirrhosis using exoglycosidase-assisted data-independent LC-MS/MS.
    Sanda M; Ahn J; Kozlik P; Goldman R
    Sci Rep; 2021 Dec; 11(1):23273. PubMed ID: 34857845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.